Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 5/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MLNR | O43193 | 1/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.51 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.51 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.51 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29757859 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL29481032 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL260266 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL30489007 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL7736643 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL6261864 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL30592537 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL260276 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL8277375 | 0.87 | MEN1 (0.42) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL10071834 | 0.87 | MEN1 (0.42) | SLC6A2SLC6A4SLC6A3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3830253-A1 | AN OMEGA-TRANSAMINASE ENZYME | University College Cork-National University of Ireland Cork (IE) | 2021-06-09 | — | — | EP | claimed |
| EP-3800178-A1 | PREPARATION OF ENAMIDE INTERMEDIATE FOR THE SYNTHESIS OF DASOTRALINE | Moehs Ibérica, S.L. (ES) | 2021-04-07 | — | — | EP | claimed |
| CN-104876812-B | Process for preparing sertraline hydrochloride intermediates and impurities | 浙江华海药业股份有限公司 | 2020-12-08 | — | — | CN | claimed |
| WO-2020025646-A1 | AN OMEGA-TRANSAMINASE ENZYME | UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK (IE) | 2020-02-06 | — | — | WO | claimed |
| EP-3604507-A1 | AN OMEGA-TRANSAMINASE ENZYME | University College Cork-National University of Ireland, Cork (IE) | 2020-02-05 | — | — | EP | claimed |
| CN-104876812-A | Method for preparing sertraline hydrochloride intermediate and impurity | ZHEJIANG HUAHAI PHARM CO LTD | 2015-09-02 | — | — | CN | claimed |
| EP-1542961-B1 | TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE FOR USE IN TREATMENT OF CNS DISORDERS | SEPRACOR INC (US) | 2013-09-11 | — | — | EP | claimed |
| WO-2010084459-A2 | IMPROVED PROCESS FOR PREPARING AN INTERMEDIATE OF SERTRALINE | PIRAMAL HEALTHCARE LIMITED (IN) | 2010-07-29 | — | — | WO | claimed |
| EP-1651590-B1 | PROCESS FOR THE PREPARATION OF AN IMINE INTERMEDIATE | EGIS GYOGYSZERGYAR NYILVANOSAN (HU) | 2008-07-30 | — | — | EP | claimed |
| WO-2007119247-A2 | IMPROVED MANUFACTURING PROCEDURE FOR THE PREPARATION OF POLYMORPHIC FORM II OF CIS-(1S)-N-METHYL-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHLENEAMINE HYDROCHLORIDE (SERTRALINE HYDROCHLORIDE) | UNICHEM LABORATORIES LIMITED (IN) | 2007-10-25 | — | — | WO | claimed |
| US-5466880-A | Process for preparing ketone enantiomer | PFIZER INC. (US) | 1995-11-14 | — | — | US | claimed |
| WO-1995015299-A1 | PROCESS FOR PREPARING A CHIRAL TETRALONE | PFIZER INC. (US) | 1995-06-08 | — | — | WO | claimed |
| EP-0616996-A1 | Enantiomeric resolution of 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-Naphthalenone | PFIZER INC. (US) | 1994-09-28 | — | — | EP | claimed |
| US-5288916-A | Contacting with liquid mixture of water and solvent containing cyclodextrin binder which selectively binds one enantiomer | BEND RESEARCH, INC. (US) | 1994-02-22 | — | — | US | claimed |
| US-5196607-A | Process for preparing ketone enantiomer | PFIZER INC. (US) | 1993-03-23 | — | — | US | claimed |
| EP-0295050-B1 | PROCESS FOR PREPARING A 4,4-DIPHENYLBUTANOIC ACID DERIVATIVE | PFIZER INC. (US) | 1991-04-17 | — | — | EP | claimed |
| EP-0341015-A2 | Improved process for preparing a ketimine | PFIZER INC. (US) | 1989-11-08 | — | — | EP | claimed |
| US-4855500-A | Process for preparing a ketimine | PFIZER INC. (US) | 1989-08-08 | — | — | US | claimed |
| US-4839104-A | Process for preparing sertraline intermediates | PFIZER, INC. (US) | 1989-06-13 | — | — | US | claimed |
| EP-0295050-A1 | Process for preparing a 4,4-diphenylbutanoic acid derivative | PFIZER INC. (US) | 1988-12-14 | — | — | EP | claimed |